Mammary fistula (n(%)). حسب Na Wang (193263)

الموضوعات:

Loss of life expectancy that would result if colorectal cancer missed in 2011 had been diagnosed in 2011 (unit: years). حسب Hiroaki Saito (24514)

الموضوعات:

Conceptual diagram of survival curve and loss of life expectancy. حسب Hiroaki Saito (24514)

الموضوعات:

Time course of best-corrected visual acuity (BCVA) in all eyes. حسب Yasuyuki Sotani (20114144)

الموضوعات:

Time course of central retinal thickness (CRT) in all eyes. حسب Yasuyuki Sotani (20114144)

الموضوعات:

Annual treatment frequencies in all eyes. حسب Yasuyuki Sotani (20114144)

الموضوعات:

Loss of life expectancy by age group and stage of colorectal cancer and change if detected after one year. حسب Hiroaki Saito (24514)

الموضوعات:

Estimated distribution of colorectal cancer stage among patients assumed to have missed diagnosis in 2011 (unit: persons). حسب Hiroaki Saito (24514)

الموضوعات:

Additional loss of life expectancy and cost per life-year saved resulting from changes in colorectal cancer stage due to a 1-year diagnostic delay. حسب Hiroaki Saito (24514)

الموضوعات:

Preoperative background characteristics of the patients. حسب Yasuyuki Sotani (20114144)

الموضوعات:

Data Sheet 1_Increasing donor kidney age significantly aggravates the negative effect of pretransplant donor-specific anti-HLA antibodies on kidney graft survival.pdf حسب Michiel G. H. Betjes (8407413)

"…Background and hypothesis<p>The presence of donor-specific anti-HLA antibodies before kidney transplantation (preDSAs) is associated with decreased graft survival. The hypothesis that increasing donor kidney age is negatively associated with the impact of preDSA on graft survival was investigated.…"

Alterations of Ceramides, Acylcarnitines, GlyceroLPLs, and Amines in NSCLC Tissues حسب Jie Zhang (64655)

الموضوعات:

Table 1_Prognostic significance of early alpha fetoprotein and des-gamma carboxy prothrombin responses in unresectable hepatocellular carcinoma patients undergoing triple combinati... حسب Teng Zhang (457128)

"…Differences in overall survival (OS), progression-free survival (PFS), and objective response rate (ORR) were assessed between the tumor biomarker response and non-response groups.</p>Results<p>Multivariate analysis indicated that AFP or DCP response at 6-8 weeks post-therapy significantly influenced ORR (high AFP cohort: odds ratio [OR] 5.50, 95% CI 2.04-14.83, p=0.001; high DCP cohort: OR 7.99, 95%CI 2.82-22.60, p<0.001). …"

The speed diagram. حسب Yifei Li (198040)

الموضوعات:

Factors of orthogonal experiment. حسب Yifei Li (198040)

الموضوعات:

Analysis of variance in orthogonal test. حسب Yifei Li (198040)

الموضوعات:

Comparison between simulation tests and bench tests. حسب Yifei Li (198040)

الموضوعات:

Schematic diagram of the millet characteristic dimensions. حسب Yifei Li (198040)

الموضوعات:

Structure and collision diagram of the millet hole seeding system. حسب Yifei Li (198040)

الموضوعات:

Analysis of variance in orthogonal test. حسب Yifei Li (198040)

الموضوعات: